Inventor
DINARELLO CHARLES A
US33 patents
⚠️ This page may combine multiple inventors who share the name “DINARELLO CHARLES A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEW ENGLAND MEDICAL CENTER INC
5 patentsUS5001057AMar 19, 1991
Truncated human IL-1 cDNA sequences which encode biologically-active human IL-1 proteins
NEW ENGLAND MEDICAL CENTER INC34 citations95
US4766069AAug 23, 1988
Recombinant DNA which codes for interleukin-1 B
NEW ENGLAND MEDICAL CENTER INC60 citations95
US5077219ADec 31, 1991
Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
NEW ENGLAND MEDICAL CENTER INC37 citations91
US5998578ADec 7, 1999
Biologically active fragments of IL-1β
NEW ENGLAND MEDICAL CENTER INC6 citations73
US5985657ANov 16, 1999
Recombinant DNA which codes for interleukin-1
NEW ENGLAND MEDICAL CENTER INC9 citations73
DINARELLO CHARLES A
4 patentsUS4434237AFeb 28, 1984
Human leukocytic pyrogen test for the detection of exogenous fever-producing substances
DINARELLO CHARLES A47 citations92
US9457070B2Oct 4, 2016
Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease
DINARELLO CHARLES A7 citations80
US8715649B2May 6, 2014
Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity
DINARELLO CHARLES A3 citations59
US9522179B2Dec 20, 2016
Compositions and methods for modulating cardiac conditions
DINARELLO CHARLES A2 citations56
OLATEC THERAPEUTICS LLC
4 patentsUS11517554B2Dec 6, 2022
Method for preventing or treating Alzheimer's disease
OLATEC THERAPEUTICS LLC2 citations73
US10548870B2Feb 4, 2020
Method for treating multiple sclerosis
OLATEC THERAPEUTICS LLC2 citations73
US11576888B2Feb 14, 2023
Methods for treating cardiovascular diseases
OLATEC THERAPEUTICS LLC3 citations69
US12318361B2Jun 3, 2025
Methods for treating cardiovascular diseases
OLATEC THERAPEUTICS LLC0 citations58
UNIV COLORADO REGENTS
4 patentsUS10450384B2Oct 22, 2019
Compositions of alpha-1 antitrypsin fusion molecules
UNIV COLORADO REGENTS2 citations73
US7560265B2Jul 14, 2009
Compositions for regulation of tumor necrosis factor-alpha
UNIV COLORADO REGENTS6 citations71
US12030958B2Jul 9, 2024
Compositions and methods of use of alpha-1 antitrypsin fusion polypeptides
UNIV COLORADO REGENTS0 citations62
US10478508B2Nov 19, 2019
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
UNIV COLORADO REGENTS0 citations52
ARES TRADING SA
3 patentsUS7875709B2Jan 25, 2011
Nucleic acids encoding interleukin-18 mutants
ARES TRADING SA10 citations84
US7279155B2Oct 9, 2007
Method of treatment using a cytokine able to bind IL-18BP to inhibit the activity of a second cytokine
ARES TRADING SA11 citations81
US7820156B2Oct 26, 2010
Method of treatment using a cytokine able to bind IL-18BP to inhibit the activity of a second cytokine
ARES TRADING SA0 citations49